Skip Navigation

European Heart Journal 1987 8(12):1312-1321;
Copyright © 1987 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by MORO, E.
Right arrow Articles by ROELANDT, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MORO, E.
Right arrow Articles by ROELANDT, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1987 The European Society of Cardiology

Genesis of systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: an anatomical or dynamic event?

E. MORO*, F. J. TEN CATE, J. J. LEONARD{dagger}, P. G. HUGENHOLTZ and J. ROELANDT

Echocardiographic Laboratory of the Thoraxcenter, Academic Hospital Rotterdam-Dijkzigt and Erasmus University Rotterdam, the Interuniversity Cardiology Institute The Netherlands

Received 22 July 1986; revised 29 May 1987; .

Jos Roelandt M.D. Thora Center, BA300, Erasmus University, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands.

To determine the relative role of both the anatomical and dynamic components involved in the determination of systolic anterior motion (SAM) of the mitral valve, we studied 53 selected patients with hypertrophic cardiomyopathy (HCM) by M-mode and cross-sectional echocardiography (CSE). Recordings of high quality for quantitative analysis were a precondition for the inclusion in the study. Twelve of these patients had no SAM, 14 had SAM of the anterior mitral leaflet (AML), six had SAM of the posterior mitral leaflet (PML), and 21 had SAM of both the AML and PML. The length of both the AML and PML, the left ventricular outflow tract (LVOT) area and the percentage of thickening of the left ventricular posterior wall (%LVPW) were measured in 18 control subjects (group I), in patients with AML-SAM (group II), in patients with AML+PML–SAM (Group III), in patients with PML-SAM (group IV) and in patients with HCM but without SAM (group V).

The length of AML in group 1 (23±1.5 mm) was significantly different compared with that in groups III (28±2 mm) and IV (29±2 mm), P<0.001. Significant differences were present in the PML-length between group I (14±1 mm) and groups III (20±3 mm) and IV (25±4 mm), respectively (P<0.001), between group II (14±2 mm) and groups III and IV, respectively (P<0.001), and also between group V (14±1 mm) and groups III and IV (P<0.001). Differences were found when the %LVPW of groups II (76+17%), III (77±11%) and IV (83±19%) were compared, respectively, with groups I (42±12%) and V (54±7%), P<0.001; a significant difference was also found between groups I and V, P<0.001. The mean LVOT area was significantly reduced in groups 11 (3.5±1.3 cm2), III (3±1 cm2) and IV (3±1 cm2) when compared with group V (5.9 cm2), P<0.001.

We conclude that the induction and maintenance of SAM in HCM is multifactorial, mainly depending on the length of both the AML and/or PML, the LVOT area and on the increased contractility of the LVPW.

Key Words: Hypertrophic cardiomyopathy • systolic anterior motion


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CirculationHome page
M. H. Yacoub
Surgical Versus Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: The Pendulum Swings
Circulation, July 26, 2005; 112(4): 450 - 452.
[Full Text] [PDF]


Home page
CirculationHome page
C. van der Lee, F. J. ten Cate, M. L. Geleijnse, M. J. Kofflard, C. Pedone, L. A. van Herwerden, E. Biagini, W. B. Vletter, and P. W. Serruys
Percutaneous Versus Surgical Treatment for Patients With Hypertrophic Obstructive Cardiomyopathy and Enlarged Anterior Mitral Valve Leaflets
Circulation, July 26, 2005; 112(4): 482 - 488.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. van der Lee, M. J.M. Kofflard, L. A. van Herwerden, W. B. Vletter, and F. J. ten Cate
Sustained Improvement After Combined Anterior Mitral Leaflet Extension and Myectomy in Hypertrophic Obstructive Cardiomyopathy
Circulation, October 28, 2003; 108(17): 2088 - 2092.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Flores-Ramirez, N. M. Lakkis, K. J. Middleton, D. Killip, W. H. Spencer III, and S. F. Nagueh
Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy
J. Am. Coll. Cardiol., January 1, 2001; 37(1): 208 - 214.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.